FDA.reportPublic FDA data

dabigatran etexilate 110 MG Oral Pellet [Pradaxa]

RxCUI
2590619
RxNorm name
dabigatran etexilate 110 MG Oral Pellet [Pradaxa]
Display name
dabigatran etexilate 110 MG Oral Pellet [Pradaxa]
Full name
dabigatran etexilate 110 MG Oral Pellet [Pradaxa]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PradaxaDABIGATRAN ETEXILATEBoehringer Ingelheim Pharmaceuticals, Inc.9ac0a64a-8666-45f7-9d4f-40fd894f7e6d2025-06-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2590619

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9ac0a64a-8666-45f7-9d4f-40fd894f7e6ddabigatran etexilate 110 MG Oral Pellet [Pradaxa]SBD7These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA ® (dabigatran etexilate) oral pellets Initial U.S. Approval: 201020250627
9ac0a64a-8666-45f7-9d4f-40fd894f7e6dPradaxa 110 MG Oral PelletSY7These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA ® (dabigatran etexilate) oral pellets Initial U.S. Approval: 201020250627
9ac0a64a-8666-45f7-9d4f-40fd894f7e6dPradaxa 110 MG Oral PelletPSN7These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA ® (dabigatran etexilate) oral pellets Initial U.S. Approval: 201020250627